Delivery Order SPE2DB22D2005-SPE2DB25FJGX9
Award Date
1/31/25
Potential Completion Date
2/3/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,836.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FLUTICASONE PROP HFA 220 MCG 12GM, a pharmaceutical product, with a period of performance through January 27, 2025. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This federal contract award, valued at $1,295.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which has a completion date of February 12, 2025, is for the delivery of FLUTICASONE PROP HFA 44 MCG 10.6GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,124.90 firm fixed-price delivery order is for the procurement of FLUTICASONE PROP HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of February 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of fluticasone propionate HFA 44 mcg 10.6 gm to the Defense Logistics Agency (DLA). The $2,846.20 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through November 4, 2024 and was not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,991.35 firm fixed-price delivery order is for the supply of FLUTICASONE PROP HFA 220 MCG 12GM, a prescription medication. The contract has an ultimate completion date of January 15, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,680.33 contract is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, and has an ultimate completion date of November 19, 2024. It is structured as a firm fixed-price delivery order, without any set-aside requirements. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,520.10 firm fixed-price delivery order is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. This award is under a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,549.54 firm fixed-price delivery order is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, with a completion date of January 9, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,511.27 firm fixed-price delivery order is for the supply of FLUTICASONE PROP HFA 220 MCG 12GM, a pharmaceutical product, with a period of performance through December 3, 2024. The contract award is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,445.49 delivery order is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, under a Firm Fixed Price contract. The award has an ultimate completion date of December 9, 2024. This delivery order is associated with a larger Indefinite Delivery...